Literature DB >> 11506212

Fracture risk in patients with muscular dystrophy and spinal muscular atrophy.

P Vestergaard1, H Glerup, B F Steffensen, L Rejnmark, J Rahbek, L Moseklide.   

Abstract

We aimed at studying fracture risk in patients with Duchenne's muscular dystrophy (DMD), Becker's muscular dystrophy (BEMD), and spinal muscular atrophy type II and III (SMA II and III). A self-administered questionnaire was mailed to 293 patients with DMD, BEMD, SMA II or SMA III of which 229 returned the questionnaire. Each respondent was compared with an age- and gender-matched control subject. The mean age was 23.9 +/- 15.9 years for the patients and 23.3 +/- 16.5 years for the controls. There were significantly more fractures among patients than controls after the diagnosis was made (RR = 1.9), but not before. The patients had more fractures of the femurs, lower legs, and upper arms than the controls. Low energy fractures were more frequent in patients than controls (9% vs 0%). Many fractures in the femurs (40%), lower legs (35%), and feet and toes (44%) led to a permanent loss of function. Loss of ambulation was the major risk factor for fractures. In conclusion, fracture risk is increased in neuromuscular disease.

Entities:  

Mesh:

Year:  2001        PMID: 11506212

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  30 in total

1.  Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatment.

Authors:  M L Bianchi; L Morandi; E Andreucci; S Vai; J Frasunkiewicz; R Cottafava
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

2.  Impaired bone homeostasis in amyotrophic lateral sclerosis mice with muscle atrophy.

Authors:  Ke Zhu; Jianxun Yi; Yajuan Xiao; Yumei Lai; Pingping Song; Wei Zheng; Hongli Jiao; Jie Fan; Chuanyue Wu; Di Chen; Jingsong Zhou; Guozhi Xiao
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

3.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

4.  Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents.

Authors:  Maria Luisa Bianchi; Sanford Baim; Nick J Bishop; Catherine M Gordon; Didier B Hans; Craig B Langman; Mary B Leonard; Heidi J Kalkwarf
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

5.  Physical training in boys with Duchenne Muscular Dystrophy: the protocol of the No Use is Disuse study.

Authors:  Merel Jansen; Imelda Jm de Groot; Nens van Alfen; Alexander Ch Geurts
Journal:  BMC Pediatr       Date:  2010-08-06       Impact factor: 2.125

6.  The chondrogenic response to exercise in the proximal femur of normal and mdx mice.

Authors:  David J Nye; Jeffrey M Costas; Jessica B Henley; Jin-Kwang Kim; Jeffrey H Plochocki
Journal:  BMC Musculoskelet Disord       Date:  2010-09-03       Impact factor: 2.362

Review 7.  Muscle-Bone Interactions in Pediatric Bone Diseases.

Authors:  Louis-Nicolas Veilleux; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

8.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

Review 9.  Muscle-Bone Crosstalk in Amyotrophic Lateral Sclerosis.

Authors:  Jingsong Zhou; Jianxun Yi; Lynda Bonewald
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

10.  Bone mineral density and bone metabolism in Duchenne muscular dystrophy.

Authors:  M L Bianchi; A Mazzanti; E Galbiati; S Saraifoger; A Dubini; F Cornelio; L Morandi
Journal:  Osteoporos Int       Date:  2003-07-29       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.